Full Committee Hearing
Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
Date:
Time:
09:45am
Location:
106 Dirksen Senate Office Building
Panel I
-
Dr. Beth Bell
Director, National Center for Emerging and Zoonotic Infectious DiseasesCenters for Disease Control and PreventionAtlanta, GA -
Dr. Peggy Hamburg
CommissionerFood and Drug AdministrationWashington, DC -
Dr. Lauren Smith
Interim CommissionerDepartment of Public HealthBoston, MA
Panel II
-
Barry Cadden
Owner and Director of PharmacyNew England Compounding CenterFramingham, MA
Panel III
-
Dr. Marion Kainer
DirectorHealthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of HealthNashville, TN -
David G. Miller
Executive Vice President and CEOInternational Academy of Compounding PharmacyMissouri City, TX -
Dr. Kasey K. Thompson
Vice President, Office of Policy, Planning and CommunicationsAmerican Society of Health-System PharmacistsBethesda, MD
Related Files
Related Transcripts
Related Issues
.jpg){kind=link}
.jpg){kind=link}
